← Back to headlines
Sarepta Therapeutics Stock Rises on Positive Muscular Dystrophy Therapy Data
Sarepta Therapeutics saw its stock increase following the release of positive data concerning its therapies for muscular dystrophy.
25 Mar, 13:49 — 25 Mar, 13:49
Sources
Showing 1 of 1 sources
